Canopy Growth Corp. has joined forces with a U.K. researcher of cannabis-based therapies after the British government moved to liberalize the use of medical marijuana.
The new company, formed with Beckley Canopy Therapeutics Ltd., aims to make products available in Britain from early this year. The government made it legal for specialist doctors to prescribe medical marijuana for patients with severe clinical need in November.
The decision came after studies showed that it could benefit children with conditions such as severe epilepsy, although the government said it was not a step toward legalizing cannabis for recreational use.
“We are witnessing...